Germany expects EMA to approve AstraZeneca vaccine on Friday
|A spokesperson for Germany's health ministry said on Monday that the European Medicines Agency (EMA) is expected to approve the coronavirus vaccine developed by AstraZeneca and Oxford University on Friday, as reported by Reuters.
Meanwhile, Sky News reported that European Union officials will be holding a virtual meeting with AstraZeneca regarding the unexpected delivery problems of the vaccine.
Market reaction
The market sentiment remains sour at the start of the week. As of writing, the Euro Stoxx 50 Index was down 0.1% on the day and Germany's DAX 30 was losing 0.15%.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.